184 related articles for article (PubMed ID: 15167291)
1. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda.
Kiwanuka N; Robb M; Kigozi G; Birx D; Philips J; Wabwire-Mangen F; Wawer MJ; Nalugoda F; Sewankambo NK; Serwadda D; Gray RH
J Acquir Immune Defic Syndr; 2004 Jun; 36(2):721-5. PubMed ID: 15167291
[TBL] [Abstract][Full Text] [Related]
2. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda.
Ruzagira E; Wandiembe S; Bufumbo L; Levin J; Price MA; Grosskurth H; Kamali A
Trop Med Int Health; 2009 Feb; 14(2):196-203. PubMed ID: 19207177
[TBL] [Abstract][Full Text] [Related]
3. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military.
McGrath JW; George K; Svilar G; Ihler E; Mafigiri D; Kabugo M; Mugisha E
J Acquir Immune Defic Syndr; 2001 Aug; 27(4):381-8. PubMed ID: 11468427
[TBL] [Abstract][Full Text] [Related]
4. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.
Asiki G; Abaasa A; Ruzagira E; Kibengo F; Bahemuka U; Mulondo J; Seeley J; Bekker LG; Delany S; Kaleebu P; Kamali A
Vaccine; 2013 Oct; 31(44):5055-61. PubMed ID: 24021306
[TBL] [Abstract][Full Text] [Related]
5. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
Priddy FH; Cheng AC; Salazar LF; Frew PM
Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
[TBL] [Abstract][Full Text] [Related]
6. Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials.
Hays RB; Kegeles SM
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):164-71. PubMed ID: 10048904
[TBL] [Abstract][Full Text] [Related]
7. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18-25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials.
Mbunda T; Tarimo EAM; Bakari M; Sandström E; Kulane A
BMC Public Health; 2019 Nov; 19(1):1537. PubMed ID: 31796002
[TBL] [Abstract][Full Text] [Related]
8. High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.
Kiwanuka N; Ssetaala A; Mpendo J; Wambuzi M; Nanvubya A; Sigirenda S; Nalutaaya A; Kato P; Nielsen L; Kaleebu P; Nalusiba J; Sewankambo NK
J Int AIDS Soc; 2013 Jul; 16(1):18621. PubMed ID: 23880102
[TBL] [Abstract][Full Text] [Related]
9. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.
Koblin BA; Holte S; Lenderking B; Heagerty P
J Acquir Immune Defic Syndr; 2000 Aug; 24(5):451-7. PubMed ID: 11035616
[TBL] [Abstract][Full Text] [Related]
10. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
[TBL] [Abstract][Full Text] [Related]
11. Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praça Onze Study Group.
Périssé AR; Schechter M; Moreira RI; do Lago RF; Santoro-Lopes G; Harrison LH
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):459-63. PubMed ID: 11141246
[TBL] [Abstract][Full Text] [Related]
12. Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
Mutisya EM; Mutua G; Nyasani D; Nduta H; Kabuti RW; Muturi-Kioi V; Omosa-Manyonyi G; Abaasa A; Lindan K; Price MA; Kimani J; Anzala AO
PLoS One; 2020; 15(8):e0238028. PubMed ID: 32834018
[TBL] [Abstract][Full Text] [Related]
13. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
Connochie D; Tingler RC; Bauermeister JA
Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
[TBL] [Abstract][Full Text] [Related]
14. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey.
Starace F; Wagner TM; Luzi AM; Cafaro L; Gallo P; Rezza G
AIDS Care; 2006 Jan; 18(1):66-72. PubMed ID: 16282079
[TBL] [Abstract][Full Text] [Related]
15. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
16. Willingness to participate in HIV vaccine research in a peri-urban South African community.
Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
[TBL] [Abstract][Full Text] [Related]
17. Willingness to Participate in Hypothetical HIV Vaccine Trial and Associated Factors among People Who Inject Drugs in Dar es Salaam, Tanzania.
Iseselo MK; Tarimo EAM; Sandstrom E; Kulane A
Biomed Res Int; 2020; 2020():8507981. PubMed ID: 32714988
[TBL] [Abstract][Full Text] [Related]
18. Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
Capitine IPU; Macicame IB; Uanela AM; Bhatt NB; Yates A; Milazzo M; Nwoga C; Crowell TA; Michael NL; Robb ML; Jani IV; Kroidl A; Polyak CS; De Schacht C;
PLoS One; 2021; 16(12):e0260126. PubMed ID: 34855790
[TBL] [Abstract][Full Text] [Related]
19. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials.
Scheer S; Douglas JM; Vittinghoff E; Bartholow BN; McKirnan D; Judson FN; MacQueen KM; Buchbinder S
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):172-8. PubMed ID: 10048905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
